Literature DB >> 22355044

Ovarian reserve status in young women is associated with altered gene expression in membrana granulosa cells.

Christine C Skiadas1, Shenghua Duan, Mick Correll, Renee Rubio, Nilay Karaca, Elizabeth S Ginsburg, John Quackenbush, Catherine Racowsky.   

Abstract

Diminished ovarian reserve (DOR) is a challenging diagnosis of infertility, as there are currently no tests to predict who may become affected with this condition, or at what age. We designed the present study to compare the gene expression profile of membrana granulosa cells from young women affected with DOR with those from egg donors of similar age and to determine if distinct genetic patterns could be identified to provide insight into the etiology of DOR. Young women with DOR were identified based on FSH level in conjunction with poor follicular development during an IVF cycle (n = 13). Egg donors with normal ovarian reserve (NOR) comprised the control group (n = 13). Granulosa cells were collected following retrieval, RNA was extracted and microarray analysis was conducted to evaluate genetic differences between the groups. Confirmatory studies were undertaken with quantitative RT-PCR (qRT-PCR). Multiple significant differences in gene expression were observed between the DOR patients and egg donors. Two genes linked with ovarian function, anti-Mullerian hormone (AMH) and luteinizing hormone receptor (LHCGR), were further analyzed with qRT-PCR in all patients. The average expression of AMH was significantly higher in egg donors (adjusted P-value = 0.01), and the average expression of LHCGR was significantly higher in DOR patients (adjusted P-value = 0.005). Expression levels for four additional genes, progesterone receptor membrane component 2 (PGRMC2), prostaglandin E receptor 3 (subtype EP3) (PTGER3), steroidogenic acute regulatory protein (StAR), and StAR-related lipid transfer domain containing 4 (StarD4), were validated in a group consisting of five NOR and five DOR patients. We conclude that gene expression analysis has substantial potential to determine which young women may be affected with DOR. More importantly, our analysis suggests that DOR patients fall into two distinct subgroups based on gene expression profiles, indicating that different mechanisms may be involved during development of this pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22355044      PMCID: PMC3378309          DOI: 10.1093/molehr/gas008

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  50 in total

Review 1.  Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals.

Authors:  Heng-Yu Fan; Qing-Yuan Sun
Journal:  Biol Reprod       Date:  2003-11-12       Impact factor: 4.285

2.  Regulation of gonadotropin receptors by luteinizing hormone in granulosa cells.

Authors:  M C Rao; J S Richards; A R Midgley; L E Reichert
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

3.  Inhibition of synthesis of luteinizing hormone (LH) receptors by a down-regulating dose of LH.

Authors:  R H Schwall; G F Erickson
Journal:  Endocrinology       Date:  1984-04       Impact factor: 4.736

4.  The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray.

Authors:  Fei-Yang Diao; Min Xu; Yanqiu Hu; Jianmin Li; Zhiyang Xu; Min Lin; Lirong Wang; Yadong Zhou; Zuomin Zhou; Jiayin Liu; Jiahao Sha
Journal:  J Mol Endocrinol       Date:  2004-08       Impact factor: 5.098

5.  Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulosa cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1.

Authors:  Kimihisa Tajima; Ada Dantes; Zhong Yao; Ksenia Sorokina; Fumikazu Kotsuji; Rony Seger; Abraham Amsterdam
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

6.  Human choriogonadotropin-induced desensitization of granulosa-cell adenylate cyclase to gonadotropins and loss of LH/hCG receptor.

Authors:  K Jääskeläinen; T Hyvönen; H Rajaniemi
Journal:  Mol Cell Endocrinol       Date:  1980-11       Impact factor: 4.102

Review 7.  Oocyte-somatic cell interactions during follicle development in mammals.

Authors:  R B Gilchrist; L J Ritter; D T Armstrong
Journal:  Anim Reprod Sci       Date:  2004-07       Impact factor: 2.145

8.  Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus.

Authors:  Seok Ho Hong; Hee Young Nah; Ji Yoon Lee; Young Jin Lee; Ji Won Lee; Myung Chan Gye; Chung Hoon Kim; Byung Moon Kang; Moon Kyoo Kim
Journal:  Mol Cells       Date:  2004-06-30       Impact factor: 5.034

9.  Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone.

Authors:  J S Richards; J J Ireland; M C Rao; G A Bernath; A R Midgley; L E Reichert
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

10.  Gonadotropin-induced gene regulation in human granulosa cells obtained from IVF patients: modulation of genes coding for growth factors and their receptors and genes involved in cancer and other diseases.

Authors:  E Rimon; R Sasson; A Dantes; A Land-Bracha; A Amsterdam
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

View more
  17 in total

1.  Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells.

Authors:  John J Peluso; Daniel Griffin; Xiufang Liu; Meghan Horne
Journal:  Biol Reprod       Date:  2014-09-24       Impact factor: 4.285

Review 2.  Non-canonical progesterone signaling in granulosa cell function.

Authors:  John J Peluso; James K Pru
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

Review 3.  Genetic associations with diminished ovarian reserve: a systematic review of the literature.

Authors:  Alexis D Greene; George Patounakis; James H Segars
Journal:  J Assist Reprod Genet       Date:  2014-05-20       Impact factor: 3.412

4.  Identification of the key regulating genes of diminished ovarian reserve (DOR) by network and gene ontology analysis.

Authors:  Maryam Pashaiasl; Mansour Ebrahimi; Esmaeil Ebrahimie
Journal:  Mol Biol Rep       Date:  2016-06-20       Impact factor: 2.316

5.  PGRMC1/2 promotes luteal vascularization and maintains the primordial follicles of mice

Authors:  John J Peluso; Xiufang Liu; Tracy Uliasz; Cindy A Pru; Nicole C Kelp; James Pru
Journal:  Reproduction       Date:  2018-10-01       Impact factor: 3.906

6.  Progesterone receptor membrane component 1 and 2 regulate granulosa cell mitosis and survival through a NFΚB-dependent mechanism†.

Authors:  John J Peluso; Cindy A Pru; Xiufang Liu; Nicole C Kelp; James K Pru
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

7.  Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin.

Authors:  Serdar Coskun; Hasan H Otu; Khalid A Awartani; Laila A Al-Alwan; Saad Al-Hassan; Hend Al-Mayman; Namik Kaya; Mehmet S Inan
Journal:  J Assist Reprod Genet       Date:  2013-02-05       Impact factor: 3.412

8.  Expression of progesterone receptor membrane component-2 within the immature rat ovary and its role in regulating mitosis and apoptosis of spontaneously immortalized granulosa cells.

Authors:  Daniel Griffin; Xiufang Liu; Cindy Pru; James K Pru; John J Peluso
Journal:  Biol Reprod       Date:  2014-07-02       Impact factor: 4.285

9.  Transcriptional characteristics of different sized follicles in relation to embryo transferability: potential role of hepatocyte growth factor signalling.

Authors:  A L Nivet; M C Léveillé; A Leader; M A Sirard
Journal:  Mol Hum Reprod       Date:  2016-04-28       Impact factor: 4.025

10.  Novel variants in women with premature ovarian function decline identified via whole-exome sequencing.

Authors:  Ruiyi Tang; Qi Yu
Journal:  J Assist Reprod Genet       Date:  2020-08-13       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.